Literature DB >> 21507493

Supply and demand for endocannabinoids.

Bradley E Alger1, Jimok Kim.   

Abstract

The endocannabinoid system consists of G-protein-coupled cannabinoid receptors that can be activated by cannabis-derived drugs and small lipids termed endocannabinoids (eCBs) plus associated biochemical machinery (precursors, synthetic and degradative enzymes, transporters). The eCB system in the brain primarily influences neuronal synaptic communication, and affects biological functions - including eating, anxiety, learning and memory, growth and development - via an array of actions throughout the nervous system. Although many aspects of synaptic regulation by eCBs are becoming clear, details of the subcellular organization and regulation of the eCB system are less well understood. This review focuses on recent investigations that illuminate fundamental issues of eCB storage, release, and functional roles.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507493      PMCID: PMC3106144          DOI: 10.1016/j.tins.2011.03.003

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  123 in total

1.  Self-modulation of neocortical pyramidal neurons by endocannabinoids.

Authors:  Silvia Marinelli; Simone Pacioni; Astrid Cannich; Giovanni Marsicano; Alberto Bacci
Journal:  Nat Neurosci       Date:  2009-11-15       Impact factor: 24.884

2.  Homer 1a gates the induction mechanism for endocannabinoid-mediated synaptic plasticity.

Authors:  Alan M Roloff; Garret R Anderson; Kirill A Martemyanov; Stanley A Thayer
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

Review 3.  New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?

Authors:  Wei Deng; James B Aimone; Fred H Gage
Journal:  Nat Rev Neurosci       Date:  2010-03-31       Impact factor: 34.870

4.  Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists.

Authors:  Talia N Lerner; Eric A Horne; Nephi Stella; Anatol C Kreitzer
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

5.  Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice.

Authors:  Ying Gao; Dmitry V Vasilyev; Maria Beatriz Goncalves; Fiona V Howell; Carl Hobbs; Melina Reisenberg; Ru Shen; Mei-Yi Zhang; Brian W Strassle; Peimin Lu; Lilly Mark; Michael J Piesla; Kangwen Deng; Evguenia V Kouranova; Robert H Ring; Garth T Whiteside; Brian Bates; Frank S Walsh; Gareth Williams; Menelas N Pangalos; Tarek A Samad; Patrick Doherty
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

6.  The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission.

Authors:  Asami Tanimura; Maya Yamazaki; Yuki Hashimotodani; Motokazu Uchigashima; Shinya Kawata; Manabu Abe; Yoshihiro Kita; Kouichi Hashimoto; Takao Shimizu; Masahiko Watanabe; Kenji Sakimura; Masanobu Kano
Journal:  Neuron       Date:  2010-02-11       Impact factor: 17.173

7.  Diacylglycerol lipase is not involved in depolarization-induced suppression of inhibition at unitary inhibitory connections in mouse hippocampus.

Authors:  Rogier Min; Guilherme Testa-Silva; Tim S Heistek; Cathrin B Canto; Johannes C Lodder; Tiziana Bisogno; Vincenzo Di Marzo; Arjen B Brussaard; Nail Burnashev; Huibert D Mansvelder
Journal:  J Neurosci       Date:  2010-02-17       Impact factor: 6.167

8.  Developmental alteration of endocannabinoid retrograde signaling in the hippocampus.

Authors:  Ping Jun Zhu; David M Lovinger
Journal:  J Neurophysiol       Date:  2009-12-09       Impact factor: 2.714

9.  Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway.

Authors:  Nan Sang; Jian Zhang; Chu Chen
Journal:  Neurochem Int       Date:  2010-01-11       Impact factor: 3.921

10.  Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.

Authors:  Jonathan Z Long; Daniel K Nomura; Robert E Vann; D Matthew Walentiny; Lamont Booker; Xin Jin; James J Burston; Laura J Sim-Selley; Aron H Lichtman; Jenny L Wiley; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

View more
  116 in total

Review 1.  Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.

Authors:  Pál Gyombolai; Dorottya Pap; Gábor Turu; Kevin J Catt; György Bagdy; László Hunyady
Journal:  Mol Cell Endocrinol       Date:  2011-11-02       Impact factor: 4.102

2.  Key questions of endocannabinoid signalling in the CNS: which, where and when?

Authors:  Charles J Frazier
Journal:  J Physiol       Date:  2011-10-15       Impact factor: 5.182

3.  Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.

Authors:  Gabriel C Loewinger; Michael V Beckert; Hugo A Tejeda; Joseph F Cheer
Journal:  Neuropharmacology       Date:  2012-01-25       Impact factor: 5.250

4.  Endocannabinoids mediate bidirectional striatal spike-timing-dependent plasticity.

Authors:  Yihui Cui; Vincent Paillé; Hao Xu; Stéphane Genet; Bruno Delord; Elodie Fino; Hugues Berry; Laurent Venance
Journal:  J Physiol       Date:  2015-05-13       Impact factor: 5.182

Review 5.  Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know.

Authors:  Bradley E Alger
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

6.  Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling.

Authors:  Stephanie C Gantz; Bruce P Bean
Journal:  Neuron       Date:  2017-03-02       Impact factor: 17.173

7.  Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity.

Authors:  B Brocato; A A Zoerner; Z Janjetovic; C Skobowiat; S Gupta; B M Moore; A Slominski; J Zhang; M Schenone; R Phinehas; R J Ferry; E Dick; G B Hubbard; G Mari; N Schlabritz-Loutsevitch
Journal:  Placenta       Date:  2013-09-02       Impact factor: 3.481

8.  Preformed vs. on-demand: molecular economics of endocannabinoid signalling.

Authors:  Charles J Frazier
Journal:  J Physiol       Date:  2013-10-01       Impact factor: 5.182

9.  Neuregulin-1 impairs the long-term depression of hippocampal inhibitory synapses by facilitating the degradation of endocannabinoid 2-AG.

Authors:  Huizhi Du; In-Kiu Kwon; Jimok Kim
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

Review 10.  Endogenous cannabinoid signaling at inhibitory interneurons.

Authors:  Thomas J Younts; Pablo E Castillo
Journal:  Curr Opin Neurobiol       Date:  2013-12-28       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.